Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J. Dann, Ron Epelbaum, Jacob M. Rowe et al.|Blood|2006Cited by 124
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J. Dann, Jacob M. Rowe, Rachel Bar‐Shalom et al.|Haematologica|2010Cited by 26
For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.Eldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2009Cited by 3
Not All Positive Interim PET/CT Scans Are Reliably Predictive for Progression Free Survival in Hodgkin Lymphoma (HL) Patients. A Proposed Model for a Functional Scoring Scale.Eldad J. Dann, Rachel Bar‐Shalom, Ada Tamir et al.|Blood|2008Cited by 1
Early Interim Negative FDG-PET/CT Is a High Predictive Factor for Progression-Free Survival in Hodgkin Lymphoma.Eldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2006Cited by 0